Sharps Technology Provides Update on Commercialization Activities and is Highlighted in Med Tech Outlook Feature Article

<p>Company advances commercialization of Securegard smart safety syringe product linethrough qualification programs with a major medical device company Production of prefilled syringe products will begin in the fourth quarter of 2023 to support the co-manufacturing agreement with Nephron Pharmaceuticals NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/sharps-technology-provides-update-on-commercialization-activities-and-is-highlighted-in-med-tech-outlook-feature-article/">Sharps Technology Provides Update on Commercialization Activities and is Highlighted in Med Tech Outlook Feature Article</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>